BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1490688)

  • 1. Continuous blood glucose measurement and insulin levels in subjects with ideal body weight, normal body weight, non-diabetic overweight and obese subjects with impaired glucose tolerance.
    Dolderer M; De la Fuente A; Kerner W; Zier H; Pfeiffer EF
    Horm Metab Res Suppl; 1992; 26():24-7. PubMed ID: 1490688
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
    Donatelli M; Terrizzi C; Russo V; Bucalo ML; Scarpinato A; Verga S; Puglisi S; Miceli G; Iraci T; Bompiani GD
    Recenti Prog Med; 1991 Jan; 82(1):1-3. PubMed ID: 2028070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of insulinemia in obese patients].
    Jakubczyk D
    Rocz Akad Med Bialymst (1989); 1990-1991; 35-36():21-42. PubMed ID: 2136545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    J Clin Invest; 1967 Oct; 46(10):1549-57. PubMed ID: 6061732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma insulin response to an orally administered glucose overload in obese and normal weight subjects (author's transl)].
    Ruiz F; Durruty P; López G; García de los Ríos M
    Rev Med Chil; 1978 May; 106(5):358-63. PubMed ID: 684304
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin response to the oral glucose tolerance test in obese patients and in subjects with a family history of diabetes mellitus].
    Fernandez Feo N; Betancourt de Breña A
    Acta Cient Venez; 1988; 39(5-6):443-6. PubMed ID: 3077893
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between insulin sensitivity and weight reduction in simple obese and obese diabetic patients.
    Ishiguro T; Sato Y; Oshida Y; Yamanouchi K; Okuyama M; Sakamoto N
    Nagoya J Med Sci; 1987 Mar; 49(1-4):61-9. PubMed ID: 3299101
    [No Abstract]   [Full Text] [Related]  

  • 10. [NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects].
    Cordera R; De Micheli A; Maiello M; Odetti P; Viviani G; Prando R; Adezati L
    Minerva Dietol Gastroenterol; 1979; 25(3):347-52. PubMed ID: 400005
    [No Abstract]   [Full Text] [Related]  

  • 11. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolical aspects after prolonged fasting in obese subjects].
    Cravetto CA; Favero A; Cravario A
    Folia Endocrinol; 1973 Apr; 26(2):139-52. PubMed ID: 4740872
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of weight reduction in obese diabetics and nondiabetics.
    Julius U; Schneider H; Leonhardt W; Hanefeld M; Gabsch HC
    Endokrinologie; 1976 Mar; 67(1):96-102. PubMed ID: 1244205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno reactive insulin responses to glycemic stimulus in maturity onset diabetics effect of severity and body weight.
    Viswanathan M; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1978 Aug; 26(8):687-93. PubMed ID: 754707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous daily blood-sugar profile in relation to serum insulin in subjects with normal metabolism and ideal or normal weight (author's transl)].
    Thum C; Laube H; Schröder KE; Raptis S; Pfeiffer EF
    Dtsch Med Wochenschr; 1975 Aug; 100(31):1595-99. PubMed ID: 1149643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of IRI after carbohydrate and aminophylline stimulation in normal, obese and diabetic subjects].
    Quartarone M; Cucinotta D; Longo G; Coglitore G; Squadrito G
    Minerva Med; 1979 May; 70(22):1629-33. PubMed ID: 450302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of weight loss on glucose tolerance in obese diabetics].
    Badran AM; Farid FF
    Journ Annu Diabetol Hotel Dieu; 1979; ():115-20. PubMed ID: 502121
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circadian variations of IRI, during fasting, in normal, obese and diabetic subjects].
    Cucinotta D; Quartarone M; Saitta A; Miceli A; Squadrito G
    Minerva Med; 1979 May; 70(23):1659-66. PubMed ID: 450306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.